Article Information
History
- August 31, 2024.
Article Versions
- Version 1 (December 21, 2022 - 14:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sierra S. Nishizaki1,2,3,4,
- Nicholas K. Haghani1,5,
- Gabriana N. La1,5,
- Natasha Ann F. Mariano1,6,
- José M. Uribe-Salazar1,5,
- Gulhan Kaya1,
- Melissa Regester3,4,
- Derek Sayre Andrews3,4,
- Christine Wu Nordahl3,4,
- David G. Amaral3,4 and
- Megan Y. Dennis1,3,4,5,†
- 1Genome Center
- 2Autism Research Training Program
- 3Department of Psychiatry and Behavioral Sciences
- 4MIND Institute
- 5Department of Biochemistry & Molecular Medicine
- 6Postbaccalaureate Research Education Program, University of California Davis, CA, USA
- ↵†Corresponding author: Megan Y. Dennis, Ph.D. University of California, Davis School of Medicine, One Shields Avenue Genome Center, 4303 GBSF Davis, CA 95616, Email: mydennis{at}ucdavis.edu
Posted August 31, 2024.
m6A-mRNA reader YTHDF2 identified as a potential risk gene in autism with disproportionate megalencephaly
